Global IV Therapy Market, Part 2

Part
01
of one
Part
01

Global IV Therapy Market, Part 2

Key Takeaways


Introduction

The research team has provided six of the top competitors in the global IV therapy industry, alongside a brief description of each company’s offering(s) in the space.

Selection of Top Competitors in Global IV Therapy

  • Becton Dickinson, B. Braun, ICU Medical, Fresenius SE & Co., Baxter International and Johnson & Johnson were selected as six top players in the global IV therapy market based on a preponderance of expert statements, which consistently rank these companies as among the largest in infusion therapy by revenue and market share.
  • In particular, Becton Dickinson, B. Braun and ICU Medical are currently the three dominant industry players by market share, and accounted for more than 50% of industry sales as of 2021, according to iData Research.

Becton Dickinson

  • Becton Dickinson (website link here) is a general manufacturer of medical and surgical equipment that currently ranks as the "leading player" in the global IV therapy industry by market share, a position that the organization has maintained since its 2015 acquisition of CareFusion.
  • At present, the company participates in every segment of the infusion therapy market and generates the most revenue in areas such as "IV sets and needless connectors."
  • Becton Dickinson more generally highlights its "IV therapy systems, solutions and devices including pumps, software, interoperability, and vascular access devices and accessories" within its owned media channels, with a particular focus on hospital end-users.
  • Additional details about the company's IV therapy offerings are directly available at these links here: 1, 2, 3.

B. Braun

  • B. Braun (website link here) is a medical products manufacturer that currently holds the second-greatest market share in the infusion therapy sector worldwide.
  • By a narrow margin, the company surpasses Becton Dickinson to take the lead position in sales of infusion pumps and stopcocks.
  • The company also is ranked second in IV sets and holds a "notable share" of revenue within the needleless connector segment of the industry.
  • In a fashion similar to Beckton Dickinson, B. Braun targets the "healthcare industry" and "healthcare professionals" for its IV therapy products.
  • Additional details about the company's IV therapy offerings are directly available at these links here: 1, 2, 3.

ICU Medical

  • ICU Medical (website link here) is a manufacturer and retailer specifically focused on "disposable medical connection systems for use in intravenous (IV) therapy applications."
  • The company currently holds the third-largest market share globally in IV therapy, after increasing its sector revenue through the acquisition of Hospira in 2017.
  • As with the preceding competitors, ICU Medical has a "strong presence" across many segments of the infusion therapy industry, particularly the "infusion pump, IV set, needleless connector, and IV stopcock device markets."
  • Additional details about the company's IV therapy offerings are directly available at these links here: 1, 2, 3.

Fresenius SE & Co.

  • Fresenius SE & Co. (website link here) is an international health care organization that specializes in products and services for dialysis, hospitals as well as at-home medical care.
  • Despite this broad focus, the company places particular emphasis on its offerings in (1) intravenously administered drugs, (2) infusion therapy, (3) clinical nutrition, including parenteral nutrition and (4) IV devices, which it highlights as four of its six primary "business fields."
  • Additional details about the company's IV therapy offerings are directly available at this link here.

Baxter International

  • Baxter International (website link here) develops healthcare products in support of a range of both chronic and acute medical conditions (e.g., hemophilia, kidney disease), which it markets primarily to health care providers, care facilities such as nursing homes and research institutions.
  • Specifically in the area of IV therapy, Baxter has been a market leader across a variety of segments, owing to its standing as the "first commercial manufacturer of prepared IV solutions" when it was founded in 1931.
  • Since then, the company has led the market through repeated product breakthroughs, such as its launch of the first "needleless" IV therapy system in 1991, the company's introduction of the first IV connector with "antimicrobial coating" in 2007 and the development of the first "flexible, plastic IV container" in 1970.
  • Additional details about the company's IV therapy offerings are directly available at these links here: 1, 2, 3.

Johnson & Johnson

  • Johnson & Johnson (website link here) is a broader provider of healthcare products and services to both consumers and medical industry end-users.
  • However, its IV therapy solutions are currently oriented towards healthcare providers, with a particular emphasis on Pharmaceutical Services (e.g., education and certification programs, supply distribution) and infusion devices.
  • Additional details about the company's IV therapy offerings are directly available at these links here: 1, 2, 3.

Research Strategy

For this research on leading competitors in the global IV therapy sector, the research team leveraged the most reputable sources available in the public domain, including iData Research, BCC Research, Transparency Market Research, Data M Intelligence and ResearchAndMarkets.

Research proposal:

Only the project owner can select the next research path.
Need related research? Let's launch your next project!
Sources
Sources